Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending September 20, 2020 Researchers identify five cognitive phenotypes in MS, Study validates OSA phenotypes in Latinos, Insomnia may have a role in generation of stressful life events, COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate, Study confirms link between PAP apnea treatment and dementia onset, More must reads Must reads for theWeek ending September 13, 2020 Lessons for patients with MS and COVID-19, Satralizumab reduces risk of severe NMOSD relapse, Exposure to DMT may delay disability accumulation in primary progressive MS, In MS, serious adverse effects are more common in rituximab versus ocrelizumab, Smoking increases risk of high plasma NfL levels in patients with MS, More must readsMust reads for theWeek ending September 6, 2020 Blood biomarkers could help predict when athletes recover from concussions, Asymptomatic children may transmit COVID-19 in communities, Sleep disorders may be undetected precursors for cardiometabolic disease in U.S. Latinos, More must readsMust reads for theWeek ending August 30, 2020 SARS-CoV-2 appears unlikely to pass through breast milk, Mortality burden of dementia may be greater than estimated, Near-hanging injuries: Critical care, psychiatric management, More must readsMust reads for theWeek ending August 23, 2020 Choroid plexuses may play a role in migraine, WHO-defined IDH molecular subgroups predict adjuvant chemotherapy benefits in low-grade glioma, The evidence is not clear: Rheumatic diseases, drugs, and COVID-19, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 last »